Lausanne - The
Court of Arbitration for Sport (CAS) on Wednesday doubled a doping ban
against Kenyan marathon star Rita Jeptoo to four years, signalling the
end of her career.
The world sports tribunal said there were aggravating circumstances
including Jeptoo's "deceptive and obstructive" behaviour, which
warranted doubling the original ban against the 2014 Chicago and Boston
The marathon titles were taken away from Jeptoo, now 35, who was also
ordered to pay $15 000 in legal
costs to the world athletics body, the IAAF.
The IAAF had appealed to the CAS to get the ban extended against
Jeptoo who was revealed to have failed a test for the blood-doping EPO
drug on October 24, 2014, 12 days after winning the Chicago Marathon.
"The panel found to its comfortable satisfaction that the athlete
used rEPO over a period of time to enhance performance," said a CAS
It added that there was "undisputed" proof that the substance had been injected by a doctor.
"The athlete provided various differing accounts of the circumstances
leading up to the injection and also regarding her relationship with
The CAS judges said they were "comfortably satisfied that there are
aggravating circumstances in the case at hand as it was obvious to the
panel that the athlete used rEPO as part of a scheme or plan."
The judges highlighted Jeptoo's "long relationship with the doctor in
question, her multiple visits to see him, that her rEPO use was
consistent with her competition calendar, that she hid the visits to the
doctor in question from her manager and coach, as well as her deceptive
and obstructive conduct throughout the proceedings."
Jeptoo's lawyer withdrew from defending her and Athletics Kenya also did not take part in the hearing.
Jeptoo, who won the Boston race three times, said last week she hoped to return to elite competition.
"I have returned to serious training with the hope that I will return
to the marathon soon," Jeptoo told AFP expressing optimism about the
The Erythropoietin (EPO) hormone, which stimulates red blood cell
production to delay fatigue, is now one of the most common doping
substances being found in athletes.